Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Itolizumab in Subjects Hospitalized With COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Itolizumab for hospitalized COVID-19 was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus

Drugs mentioned

• Itolizumab (Itolizumab)

Snippet

Sponsor: Equillium | Conditions: Coronavirus | Phase 3 | Status: WITHDRAWN